Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.

@article{Cadario2007SublingualIE,
  title={Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.},
  author={Gianni Cadario and Antonia G Galluccio and Michele Pezza and Antonella Appino and Massimo Milani and Silvia Pecora and Fulvio Mastrandrea},
  journal={Current medical research and opinion},
  year={2007},
  volume={23 10},
  pages={2503-6}
}
BACKGROUND Specific subcutaneous immunotherapy (SCIT) with house dust mite (HDM) preparation has recently been shown to improve eczema in patients with atopic dermatitis (AD). So far, there is less data regarding efficacy and safety of specific sublingual immunotherapy (SLIT) in patients with AD. STUDY AIM To evaluate in an open non-controlled, non-randomized pilot trial the effect of SLIT with HDM allergen extracts preparation (SLITone, ALK Abellò Italy) on SCORAD in adult patients with mild… CONTINUE READING